Complete SCYX Stock Valuation Analysis
Comprehensive intrinsic value analysis using 2 different methodologies
SCYX DCF Analysis
SCYX (SCYNEXIS, Inc.) discounted cash flow analysis with multiple scenarios, growth assumptions, and terminal value calculations
Financial Projections
| Metrics | 2022 (Historical) | 2023 (Historical) | 2024 (Historical) | 2025 (Projected) | 2026 (Projected) | 2027 (Projected) | 2028 (Projected) | 2029 (Projected) |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.1M | $140.1M | $3.7M | $4.7M | $5.9M | $7.3M | $9.1M | $11.4M |
| Revenue Growth % | - | 2652.7% | -97.3% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% |
| EBIT | $-85.8M | $72.7M | $-37.1M | $234.1K | $292.7K | $365.8K | $457.3K | $571.6K |
| EBIT Margin % | -1684.5% | 51.9% | -990.8% | 5.0% | 5.0% | 5.0% | 5.0% | 5.0% |
| Tax Rate % | 25.0% | 0.2% | 25.0% | 20.0% | 20.5% | 21.0% | 21.5% | 22.0% |
| NOPAT | $-64.3M | $72.5M | $-27.8M | $187.2K | $232.6K | $288.9K | $358.8K | $445.7K |
| NOPAT Margin % | -1263.4% | 51.7% | -743.1% | 4.0% | 4.0% | 3.9% | 3.9% | 3.9% |
| Capex | $9.0K | $0 | $0 | $106.3K | $126.2K | $149.9K | $178.0K | $211.4K |
| Capex / Revenue % | 0.2% | 0.0% | 0.0% | 2.3% | 2.2% | 2.0% | 1.9% | 1.8% |
| Depreciation | $606.0K | $580.0K | $1.7M | $911.4K | $1.1M | $1.4M | $1.8M | $2.2M |
| D&A / Revenue % | 11.9% | 0.4% | 46.1% | 19.5% | 19.5% | 19.5% | 19.5% | 19.5% |
| Change in NWC | $-34.3M | $24.4M | $-37.7M | $46.8K | $58.5K | $73.2K | $91.5K | $114.3K |
| NWC Change / Revenue % | -674.1% | 17.4% | -1007.2% | 1.0% | 1.0% | 1.0% | 1.0% | 1.0% |
| Unlevered FCF | $-29.4M | $48.7M | $11.6M | $945.5K | $1.2M | $1.5M | $1.9M | $2.3M |
| UFCF % Chg. | - | 265.7% | -76.2% | -91.9% | 25.5% | 25.5% | 25.5% | 25.4% |
| FCF / Revenue % | -577.5% | 34.8% | 310.2% | 20.2% | 20.3% | 20.4% | 20.4% | 20.5% |
| Discount Factor | - | - | - | 0.913 | 0.833 | 0.761 | 0.694 | 0.634 |
| Present Value of FCF | - | - | - | $863.1K | $989.2K | $1.1M | $1.3M | $1.5M |
| Sum of PV of UFCF | - | - | - | $863.1K | $1.9M | $3.0M | $4.3M | $5.8M |
WACC Calculation
Weighted Average Cost of Capital used for discounting cash flows.
| WACC Calculation | Value |
|---|---|
| Cost of Debt | 6.9% |
| Tax Rate | 20.0% |
| After Tax Cost of Debt | 5.5% |
| Risk Free Rate | 4.37% |
| Market Risk Premium | 4.3% |
| Beta | 1.65 |
| Cost of Equity | 11.5% |
| Total Debt | $16.3M |
| Market Cap | $33.4M |
| Total Capital | $49.7M |
| Debt Weighting | 32.8% |
| Equity Weighting | 67.2% |
| WACC | 9.5% |
Terminal Value
Choose between perpetuity growth or exit multiple methods.
| Terminal Value Calculation | Value |
|---|---|
| Terminal Growth Rate | 2.5% |
| Final Year FCF | $2.3M |
| Terminal Value | $34.1M |
| PV of Terminal Value | $21.6M |
| Cumulative PV of UFCF | $5.8M |
| Net Debt | $219.0K |
| Equity Value | $27.2M |
| Shares Outstanding | 48.5M |
| Implied Share Price | $1 |
| Current Share Price | $1 |
| Implied Upside/(Downside) | -34.5% |
Valuation Summary
$0.56
Implied Price
$0.86
Current Price
-34.5%
Upside/Downside
9.5%
WACC
SCYX Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 6 peer companies in Healthcare
P/E Ratio
$-33.86
-4056.9%
Peer Median: 61.8x
EV/EBITDA
$0.00
-100.0%
Peer Median: 45.1x
P/S Ratio
$0.86
+0.0%
Peer Median: 14.1x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for SCYX's business model and current situation.
Multiple Comparison
| Multiple | SCYX Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -1.6x | 61.8x | 61.8x | -102.5% | Undervalued |
| EV/EBITDA | Infinityx | 45.1x | 45.1x | Infinity% | Overvalued |
| P/S Ratio | 14.1x | 14.1x | 9.9x | 0.0% | Fair Value |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $0.04B | 0.0x | 0.0x | 0.9x | |
| $0.03B | 0.0x | 0.0x | 14.1x | |
| $0.03B | 0.0x | 0.0x | 17.1x | |
| $0.03B | 0.0x | 0.0x | 0.0x | |
| $0.03B | 0.0x | 0.0x | 3.0x | |
| $722.17B | 61.8x | 45.1x | 14.7x |